ASPECTS (Alberta Stroke Program Early CT Score) Calculator

Clinical calculation support · Verify results before clinical use

Assess early ischemic changes

Mark each ASPECTS region showing early ischemic change on non-contrast CT.

— ASPECTS

Select all regions that show hypoattenuation, loss of gray–white matter differentiation, or focal sulcal effacement. Each selected region subtracts one point from 10.

About ASPECTS

The Alberta Stroke Program Early CT Score is a 10-point imaging score used to describe early ischemic changes in the middle cerebral artery (MCA) territory on non-contrast head CT. The starting score is 10; one point is subtracted for each of the 10 defined regions with early ischemic change. A score of 10 means no early ischemic change is identified in the scored regions; 0 means all 10 regions are affected.

Scored regions

RegionAnatomical description
CCaudate head. Subcortical region.
LLentiform nucleus. Putamen and globus pallidus.
ICInternal capsule. Subcortical region.
IInsular ribbon. Insular region.
M1Anterior MCA cortex. Frontal operculum.
M2Lateral MCA cortex. Lateral to the insular ribbon; anterior temporal region.
M3Posterior MCA cortex. Posterior temporal region.
M4Superior anterior MCA cortex. Supraganglionic region.
M5Superior lateral MCA cortex. Supraganglionic region.
M6Superior posterior MCA cortex. Supraganglionic region.

Interpretation and limitations

Higher scores generally indicate fewer scored regions with visible early ischemic change, but ASPECTS is not a direct infarct-volume measurement. Region location, image quality, reader experience, timing, and modality can affect assessment. The standard score is designed for the MCA territory and does not assess all vascular territories.

ASPECTS may contribute to acute ischemic stroke assessment and reperfusion-treatment decisions, but should not be used as a stand-alone treatment rule. Do not infer treatment eligibility, futility, or an individual patient's prognosis from this score alone. Consider symptom onset/last-known-well, neurological deficit, vessel imaging, other imaging findings, contraindications, local protocols, and current stroke guidelines.

References

Barber PA, Demchuk AM, Zhang J, Buchan AM.Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. The Lancet. 2000;355(9216):1670–1674. DOI record. PMID: 10905241; DOI: 10.1016/S0140-6736(00)02237-6.
Schröder J, Thomalla G.A Critical Review of Alberta Stroke Program Early CT Score for Evaluation of Acute Stroke Imaging. Frontiers in Neurology. 2017;7:245. DOI: 10.3389/fneur.2016.00245.
Winkelmeier L, Maros M, Flottmann F, et al.Endovascular Thrombectomy for Large Ischemic Strokes with ASPECTS 0–2: a Meta-analysis of Randomized Controlled Trials. Clinical Neuroradiology. 2024;34:713–718. This evidence informs the caution against treating a low score as an automatic exclusion; applicability depends on the clinical scenario and current guidance.
Prabhakaran S, Gonzalez NR, Zachrison KS, et al.2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2026. DOI: 10.1161/STR.0000000000000513. The guideline includes selected thrombectomy pathways for ASPECTS 3–5 and, in some circumstances, ASPECTS 0–2; ASPECTS alone is not a complete eligibility assessment.